Osteosarcoma

Active Research Protocols

  1. 07-C-0040 – A Phase I Trial of Monoclonal Antibody HGS-ETR2 (Lexatumumab) with or without Interferon Gamma in Patients with Refractory Pediatric Solid Tumors
  2. 08-C-0080 – SARC Global Collaboration: A Phase II Trial of R1507, a Recombinant Human Monoclonal Antibody to the IGF-1 Receptor for the Treatment of Patients with Recurrent or Refractory Ewing's Sarcoma, Synovial Sarcoma, Rhabdomyosarcoma and Other Sarcomas
  3. 09-C-0054 – A Group Wide Biology and Banking Study for Phase II Study of R1507
  4. 09-C-0104 – A Randomized, Double-Blinded, Placebo-Controlled, Multi-Institutional, Cross-Over, Phase II.5 Study of Saracatinib (AZD0530), a Selective Src Kinase Inhibitor, In Patients with Recurrent Osteosarcoma Localized to the Lung
  5. 10-C-0178 – A Phase 1/2 Study of PF-02341066, an Oral Small Molecule Inhibitor of Anaplastic Lymphoma Kinase (ALK) and C-Met, in Children with Relapsed/Refractory Solid Tumors and Anaplastic Large Cell Lymphoma
  6. 98-C-0037 – Treatment of Children with Cancer
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014